|
LOC646762 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.938300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.357700E-03 |
| Normal-vs-Stage2 |
1.603600E-01 |
| Normal-vs-Stage3 |
1.310160E-01 |
| Normal-vs-Stage4 |
2.150600E-01 |
| Stage1-vs-Stage2 |
8.509200E-01 |
| Stage1-vs-Stage3 |
1.796990E-01 |
| Stage1-vs-Stage4 |
1.837610E-01 |
| Stage2-vs-Stage3 |
4.599600E-01 |
| Stage2-vs-Stage4 |
4.244200E-01 |
| Stage3-vs-Stage4 |
8.838000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.304200E-03 |
| Normal-vs-AfricanAmerican |
3.370400E-01 |
| Normal-vs-Asian |
1.619990E-01 |
| Caucasian-vs-AfricanAmerican |
4.906400E-01 |
| Caucasian-vs-Asian |
1.116970E-01 |
| AfricanAmerican-vs-Asian |
9.344300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.318310E-02 |
| Normal-vs-Female |
5.519700E-03 |
| Male-vs-Female |
6.317600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.295620E-01 |
| Normal-vs-Age(41-60Yrs) |
7.819500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.712190E-02 |
| Normal-vs-Age(81-100Yrs) |
9.229200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.504400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.371200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.884850E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.243600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.473000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.496200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.55490000000236E-05 |
| Normal-vs-Grade 2 |
2.898700E-03 |
| Normal-vs-Grade 3 |
5.276300E-02 |
| Normal-vs-Grade 4 |
2.037800E-01 |
| Grade 1-vs-Grade 2 |
4.251600E-02 |
| Grade 1-vs-Grade 3 |
4.969900E-02 |
| Grade 1-vs-Grade 4 |
3.623900E-02 |
| Grade 2-vs-Grade 3 |
4.319600E-01 |
| Grade 2-vs-Grade 4 |
4.142200E-01 |
| Grade 3-vs-Grade 4 |
8.590200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.883690E-03 |
| Normal-vs-ccB subtype |
3.922100E-02 |
| ccA subtype-vs-ccB subtype |
5.061200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.993800E-02 |
| Normal-vs-N1 |
5.321200E-01 |
| N0-vs-N1 |
9.206800E-01 |
|
|
